Caris Life Sciences (CAI) P/B ratio

P/B ratio today
5.8×

Only 1 fiscal year of P/B ratio is on record here for Caris Life Sciences (CAI); a history needs at least 3. Caris Life Sciences (CAI) trades at 5.8× its book value per share at the end of fiscal 2025. Figures as of 18 Nov 2026, 08:28 UTC, from Yahoo Finance.

Key facts

P/B ratio today
5.8×
P/B ratio, fiscal 2025
7.8×
Fiscal years on record
12025–2025

Figures as of . Statements from Yahoo Finance. Figures, not advice.

Not enough data

A history of P/B ratio needs at least 3 fiscal years; one is on record here for Caris Life Sciences. Nothing is estimated to fill the gap. What is on record is in the table below.

Caris Life Sciences P/B ratio, year by year

Caris Life Sciences (CAI) P/B ratio by fiscal year
Fiscal yearP/B ratioChangeYear endedShare price at year-endBook value per share
Today5.8×—$19.94—
20257.8×—$26.98$3.45
2024———-$8.99
2023———-$8.42
2022———-$6.68

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/B ratio is the share price divided by book value per share — shareholders' equity on the balance sheet divided by the share count — at each fiscal year-end; a year with negative equity has no P/B.

How to read it

It compares the price with the accounting value of what the company owns net of what it owes, and matters most for banks, insurers and other balance-sheet businesses.

P/B ratio at health care companies of similar size

P/B ratio of Caris Life Sciences and comparable companies
CompanyP/B ratio
Bausch + Lomb BLCO1.2×
Caris Life Sciences CAI9.9×
Immunovant IMVT8.1×

Today's market value divided by shareholders' equity at the latest fiscal year-end. A company whose statements are in another currency than its shares is left out.

More on CAI

Caris Life Sciences, figure by figure

Caris Life Sciences (CAI) overview: price, valuation and scorecardAll health care companies by market value

Caris Life Sciences P/B ratio: questions and answers

What is Caris Life Sciences's P/B ratio?

Caris Life Sciences (CAI) trades at 5.8× its book value per share at the end of fiscal 2025.

How is Caris Life Sciences's P/B ratio calculated?

The P/B ratio is the share price divided by book value per share — shareholders' equity on the balance sheet divided by the share count — at each fiscal year-end; a year with negative equity has no P/B.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Caris Life Sciences (CAI) P/B ratio”, data as of 18 November 2026. https://funkfolio.com/stock/CAI/pb-ratio

Underlying data: Yahoo Finance.